These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7681523)

  • 21. Sequential histologic study of rat liver during peroxisome proliferator [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]-acetic acid (Wy-14,643)-induced carcinogenesis.
    Rao MS; Lalwani ND; Reddy JK
    J Natl Cancer Inst; 1984 Oct; 73(4):983-90. PubMed ID: 6592391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
    Lake BG; Evans JG; Cunninghame ME; Price RJ
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes.
    Eckl PM; Ortner A; Esterbauer H
    Mutat Res; 1993 Dec; 290(2):183-92. PubMed ID: 7694109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.
    Conway JG; Tomaszewski KE; Olson MJ; Cattley RC; Marsman DS; Popp JA
    Carcinogenesis; 1989 Mar; 10(3):513-9. PubMed ID: 2924396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643.
    Obourn JD; Frame SR; Bell RH; Longnecker DS; Elliott GS; Cook JC
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):425-36. PubMed ID: 9266817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The peroxisome proliferations WY-14,643 and methylclofenapate induce hepatocyte ploidy alterations and ploidy-specific DNA synthesis in F344 rats.
    Miller RT; Shah RS; Cattley RC; Popp JA
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):317-23. PubMed ID: 8658533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha.
    Pogribny IP; Tryndyak VP; Woods CG; Witt SE; Rusyn I
    Mutat Res; 2007 Dec; 625(1-2):62-71. PubMed ID: 17586532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate.
    Watanabe T; Lalwani ND; Reddy JK
    Biochem J; 1985 May; 227(3):767-75. PubMed ID: 4004798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect on the expression of c-met, c-myc and PPAR-alpha in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643.
    Miller RT; Glover SE; Stewart WS; Corton JC; Popp JA; Cattley RC
    Carcinogenesis; 1996 Jun; 17(6):1337-41. PubMed ID: 8681452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wy-14,643, a peroxisome proliferator, inhibits compensative cell proliferation and hepatocyte growth factor mRNA expression in the rat liver.
    Motoki Y; Tamura H; Watanabe T; Suga T
    Cancer Lett; 1999 Jan; 135(2):145-50. PubMed ID: 10096422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased hepatocyte growth factor level by Wy-14,643, non-genotoxic hepatocarcinogen in F-344 rats.
    Motoki Y; Tamura H; Morita R; Watanabe T; Suga T
    Carcinogenesis; 1997 Jul; 18(7):1303-9. PubMed ID: 9230272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of comitogenicity by the peroxisome proliferator hepatocarcinogens, Wy-14,643 and clofibric acid.
    Marsman DS; Swanson-Pfeiffer CL; Popp JA
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):1-6. PubMed ID: 8378924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicity studies of WY-14,643 (CAS No. 50892-23-4) administered in feed to male Sprague-Dawley rats, B6C3F1 mice, and Syrian hamsters.
    Cunningham ML
    Toxic Rep Ser; 2007 Oct; (62):1-136. PubMed ID: 24743700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic and genotoxic effects of beta-carotene breakdown products on primary rat hepatocytes.
    Alija AJ; Bresgen N; Sommerburg O; Siems W; Eckl PM
    Carcinogenesis; 2004 May; 25(5):827-31. PubMed ID: 14688018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the genetic toxicity of the peroxisome proliferator and carcinogen methyl clofenapate, including assays using Muta Mouse and Big Blue transgenic mice.
    Lefevre PA; Tinwell H; Galloway SM; Hill R; Mackay JM; Elcombe CR; Foster J; Randall V; Callander RD; Ashby J
    Hum Exp Toxicol; 1994 Nov; 13(11):764-75. PubMed ID: 7857696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
    Woods CG; Burns AM; Bradford BU; Ross PK; Kosyk O; Swenberg JA; Cunningham ML; Rusyn I
    Toxicol Sci; 2007 Aug; 98(2):366-74. PubMed ID: 17483499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement by peroxisome proliferators of the susceptibility to DNA damage in the liver of male F344 rats.
    Hayashi F; Tamura H; Watanabe T; Suga T
    Cancer Lett; 1995 May; 92(1):87-90. PubMed ID: 7757964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression.
    Woods CG; Kosyk O; Bradford BU; Ross PK; Burns AM; Cunningham ML; Qu P; Ibrahim JG; Rusyn I
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):267-77. PubMed ID: 17950772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nongenotoxic hepatocarcinogen Wy-14,643 is an uncoupler of oxidative phosphorylation in vivo.
    Keller BJ; Bradford BU; Marsman DS; Cattley RC; Popp JA; Bojes HK; Thurman RG
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):52-8. PubMed ID: 8470123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.
    Gupta RC; Goel SK; Earley K; Singh B; Reddy JK
    Carcinogenesis; 1985 Jun; 6(6):933-6. PubMed ID: 4006083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.